Sarcoma and Rare Cancers 2024 – Sarcoma and Rare Cancers 2024
All times are listed in CET (Central European
All times are listed in CET (Central European
Tisotumab vedotin-tftv may now be given to patients with recurrent or metastatic cervical cancer, according to the FDA.
Here, we summarize an analysis of CD19-targeting CAR T-cell therapy in patients with PCNSL or SCNSL, presented by Ossami Saidy during the 50th Annual Meeting…
OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts,
Vebreltinib has received approval from China’s NMPA in pretreated IDH-mutant, PTPRZ1-MET fusion–positive astrocytoma or glioblastoma.
Unfortunately the website is temporarily unavailable. We are working to fix the issue and it should be back online shortly. We apologise for an inconvenience…
The integration of Artificial Intelligence (AI) in oncology is a developing field, impacting the doctor-patient relationship and the efficacy of cance…
Facing close competition for re-election and concerted pushback from the tobacco industry and its allies, the US Government administration of President Joe Biden has delayed…
Funding is urgently needed to support end-of-life care for patients in hospices across the UK, according to general consensus during a parliamentary debate in the…
Cristina Papayannidis, MD, PhD, University of Bologna, Bologna, Italy, summarizes the current standard of care (SoC) for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.